Thermo Fisher Scientific R&D decreased by 1.8% to $336.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.8%, from $342.00M to $336.00M. Over 3 years (FY 2021 to FY 2024), R&D shows relatively stable performance with a -0.4% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
High spending signals a commitment to future growth and innovation, though it reduces current period earnings.
Detailed definition
Expenses related to the development of new products, services, and technologies, as well as the improvement of existing...
Peer comparison
Tech leaders often spend a significant percentage of revenue on R&D to prevent disruption by competitors.
Metric ID:
research_and_developmentHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $343.00M | $351.00M | $392.00M | $364.00M | $365.00M | $351.00M | $391.00M | $346.00M | $345.00M | $319.00M | $327.00M | $331.00M | $339.00M | $346.00M | $374.00M | $342.00M | $336.00M |
| QoQ Change | — | +2.3% | +11.7% | -7.1% | +0.3% | -3.8% | +11.4% | -11.5% | -0.3% | -7.5% | +2.5% | +1.2% | +2.4% | +2.1% | +8.1% | -8.6% | -1.8% |
| YoY Change | — | — | — | — | +6.4% | +0.0% | -0.3% | -4.9% | -5.5% | -9.1% | -16.4% | -4.3% | -1.7% | +8.5% | +14.4% | +3.3% | -1.8% |
Range$319.00M – $392.00M
CAGR-0.5%
Avg YoY Growth-0.9%
Median YoY Growth-1.7%
Current Streak2 quarters decline
Business Segments
| Segment | Q3 '25 | Q1 '26 |
|---|---|---|
| Analytical Instruments | $144.00M | $139.00M |
| Life Sciences Solutions | $136.00M | $131.00M |
| Specialty Diagnostics | $42.00M | $44.00M |
| Laboratory Products and Biopharma Services | $14.00M | $15.00M |
| Total | — | $336.00M |
R&D at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's r&d?
- Thermo Fisher Scientific (TMO) reported r&d of $336.00M in Q1 2026.
- How has Thermo Fisher Scientific's r&d changed year-over-year?
- Thermo Fisher Scientific's r&d decreased by 1.8% year-over-year, from $342.00M to $336.00M.
- What is the long-term trend for Thermo Fisher Scientific's r&d?
- Over 3 years (2021 to 2024), Thermo Fisher Scientific's r&d has grown at a -0.4% compound annual growth rate (CAGR), from $1.41B to $1.39B.
- What does r&d mean?
- The money spent on creating new technology and improving existing products.